1. Home
  2. PFBC vs MLYS Comparison

PFBC vs MLYS Comparison

Compare PFBC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFBC
  • MLYS
  • Stock Information
  • Founded
  • PFBC 1991
  • MLYS 2019
  • Country
  • PFBC United States
  • MLYS United States
  • Employees
  • PFBC N/A
  • MLYS N/A
  • Industry
  • PFBC Major Banks
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFBC Finance
  • MLYS Health Care
  • Exchange
  • PFBC Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • PFBC 1.1B
  • MLYS 890.6M
  • IPO Year
  • PFBC 1998
  • MLYS 2023
  • Fundamental
  • Price
  • PFBC $93.81
  • MLYS $37.01
  • Analyst Decision
  • PFBC Hold
  • MLYS Strong Buy
  • Analyst Count
  • PFBC 3
  • MLYS 6
  • Target Price
  • PFBC $103.67
  • MLYS $42.60
  • AVG Volume (30 Days)
  • PFBC 64.3K
  • MLYS 2.6M
  • Earning Date
  • PFBC 10-20-2025
  • MLYS 11-10-2025
  • Dividend Yield
  • PFBC 3.19%
  • MLYS N/A
  • EPS Growth
  • PFBC N/A
  • MLYS N/A
  • EPS
  • PFBC 9.51
  • MLYS N/A
  • Revenue
  • PFBC $267,978,999.00
  • MLYS N/A
  • Revenue This Year
  • PFBC $2.56
  • MLYS N/A
  • Revenue Next Year
  • PFBC $3.42
  • MLYS N/A
  • P/E Ratio
  • PFBC $9.90
  • MLYS N/A
  • Revenue Growth
  • PFBC 1.62
  • MLYS N/A
  • 52 Week Low
  • PFBC $71.90
  • MLYS $8.24
  • 52 Week High
  • PFBC $99.78
  • MLYS $39.20
  • Technical
  • Relative Strength Index (RSI)
  • PFBC 51.23
  • MLYS 85.99
  • Support Level
  • PFBC $94.28
  • MLYS $35.00
  • Resistance Level
  • PFBC $95.23
  • MLYS $39.20
  • Average True Range (ATR)
  • PFBC 1.65
  • MLYS 2.55
  • MACD
  • PFBC -0.13
  • MLYS 1.70
  • Stochastic Oscillator
  • PFBC 24.40
  • MLYS 91.00

About PFBC Preferred Bank

Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: